Viewing nowCombinationLosartan Plus Tablet
Losartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Hanol Bio Pharma Co., Ltd.

MFDS item code 200607707 · Notified 2006.10.27 · Insurance code 655600440
Treatment of hypertension not controlled with monotherapy
This medication is used for patients with hypertension whose blood pressure control is insufficient with monotherapy. Hypertension refers to a condition where blood pressure remains consistently high, which can increase the risk of cardiovascular complications if not managed appropriately. Therefore, this medication helps to lower and manage blood pressure more effectively when used in combination with other treatments. It is used to improve blood pressure control according to the patient's condition.
○ Adults The usual dose of this drug is 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. Doses exceeding losartan potassium 100 mg/hydrochlorothiazide 25 mg per day are not recommended. In general, the maximum blood pressure-lowering effect is achieved approximately 3 weeks after starting treatment. This drug may be administered with other antihypertensive agents and may be taken with or without food. To minimize adverse reactions, start this drug only when the desired effect has not been achieved with monotherapy. 1. Substitution therapy: This drug may replace combination therapy with individually dose-adjusted losartan potassium and hydrochlorothiazide. 2. Patients whose blood pressure is not controlled with losartan or hydrochlorothiazide monotherapy: Start with 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 3. Patients whose blood pressure is not controlled with losartan potassium 100 mg monotherapy: Start with losartan potassium 100 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 4. Patients whose blood pressure is not controlled with hydrochlorothiazide 25 mg once daily, or who have hypokalemia even when blood pressure is controlled at this dose: Treatment may be initiated with 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily, which can reduce the hydrochlorothiazide dose without reducing the overall blood pressure-lowering effect. The clinical response to losartan potassium 50 mg/hydrochlorothiazide 12.5 mg should then be monitored continuously; if blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. ○ Patients with renal impairment The usual dose may be administered when creatinine clearance is 30 mL/min or greater. Use of loop diuretics rather than thiazide-type drugs is preferable in patients with more severe renal impairment; therefore, administration to these patients is not recommended. ○ Patients with hepatic impairment Administration to these patients is not recommended because the initial dose of losartan potassium for patients with hepatic impairment requiring dose adjustment, 25 mg, cannot be administered with this drug.
Pediatric patients (under 18 years): There is no experience with use in children and adolescents; therefore, the losartan-hydrochlorothiazide combination should not be administered to children or adolescents.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. This medication should not be used by patients with certain conditions or those who have hypersensitivity to the medication, and caution is also required for patients with severely impaired kidney or liver function. Patients with excessively low blood pressure or electrolyte imbalances, as well as those with hyperuricemia or gout, should exercise caution when taking this medication. During the course of treatment, blood pressure, renal function, and serum electrolyte levels should be regularly monitored to ensure there are no abnormalities. The hydrochlorothiazide component can cause electrolyte imbalances, elevated blood sugar levels, and hypersensitivity reactions, so it is important to monitor the patient's condition closely. When this medication is used in combination with other antihypertensive medications, potassium-sparing diuretics, or potassium supplements, potassium levels may become dangerously high, so consultation with a physician is necessary. There may be dizziness or drowsiness while driving or operating machinery, so caution is needed. If sudden skin rashes, difficulty breathing, or facial swelling occur during treatment, immediate notification of healthcare personnel is necessary. This medication is not to be used in children or adolescents, and elderly patients should take it according to healthcare instructions due to a higher likelihood of side effects. Women of childbearing potential should confirm their pregnancy status before taking this medication, and nursing mothers should either avoid taking it or stop breastfeeding. In case of overdose while taking the medication, symptoms such as hypotension or arrhythmias may occur, so prescribed dosages must be adhered to. This medication should be stored in a tightly closed container that shields it from light, in a cool and dry place out of reach of children, preferably in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a closed container that can shield it from light, and it is safe to keep it at room temperature between 1 degree to 30 degrees Celsius. Storing it this way can maintain the drug's effectiveness and prevent deterioration.
Yellow oval film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Hanol Bio Pharma Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Yuhan
CombinationLosartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
(Co., Ltd. ) Yuyoung Pharmaceutical
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Youngpoong Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Kolon Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Dongkwang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.